Profil
Sharon Morani currently works at Vigil Neuroscience, Inc., as Senior Director-Facilities & Operations from 2024.
Ms. Morani also formerly worked at Atlas Venture Advisors, Inc., as Director-Portfolio Operations from 2019 to 2022 and WebLayers, Inc., as Director from 2008 to 2009.
Ms. Morani received her undergraduate degree from Salem State University.
Postes actifs de Sharon Morani
| Sociétés | Poste | Début |
|---|---|---|
| VIGIL NEUROSCIENCE, INC. | Directeur des opérations | 01/06/2022 |
Anciens postes connus de Sharon Morani
| Sociétés | Poste | Fin |
|---|---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 01/06/2022 |
WebLayers, Inc.
WebLayers, Inc. Packaged SoftwareTechnology Services Develops automated software testing solutions | Private Equity Investor | 01/02/2009 |
Formation de Sharon Morani
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Salem State University
Salem State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WebLayers, Inc.
WebLayers, Inc. Packaged SoftwareTechnology Services Develops automated software testing solutions | Technology Services |
Vigil Neuroscience, Inc.
Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
















